Log in
Enquire now
‌

US Patent 7524880 Crystalline form of a substituted pyrrolidine compound

Patent 7524880 was granted and assigned to Theravance on April, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Theravance
Theravance
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
75248800
Patent Inventor Names
Weijiang Zhang0
Yu-Hua Ji0
Adam Hughes0
Davar Khossravi0
Li Li0
Robert Chao0
Date of Patent
April 28, 2009
0
Patent Application Number
111487280
Date Filed
June 9, 2005
0
Patent Citations Received
‌
US Patent 11858898 Crystalline freebase forms of a biphenyl compound
0
Patent Primary Examiner
‌
Rei Tsang Shiao
0
Patent abstract

The invention provides a crystalline naphthalene-1,5-disulfonic acid salt of 2-[(S)-1-(8-methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide or a solvate thereof. This invention also provides pharmaceutical compositions comprising the salt or prepared using the salt; processes and intermediates for preparing the salt; and methods of using the salt to treat a pulmonary disorder.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7524880 Crystalline form of a substituted pyrrolidine compound

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.